Cardillo, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 4.109
AS - Asia 2.279
EU - Europa 2.089
SA - Sud America 534
Continente sconosciuto - Info sul continente non disponibili 117
AF - Africa 42
OC - Oceania 8
Totale 9.178
Nazione #
US - Stati Uniti d'America 4.002
SG - Singapore 999
CN - Cina 532
BR - Brasile 430
DE - Germania 414
PL - Polonia 317
IT - Italia 305
SE - Svezia 237
VN - Vietnam 225
UA - Ucraina 187
FR - Francia 155
IE - Irlanda 101
IN - India 101
FI - Finlandia 91
RU - Federazione Russa 85
GB - Regno Unito 83
ID - Indonesia 72
BD - Bangladesh 67
HK - Hong Kong 51
AR - Argentina 47
CA - Canada 44
JP - Giappone 44
TR - Turchia 39
MX - Messico 33
IQ - Iraq 32
BE - Belgio 28
NL - Olanda 22
KR - Corea 21
IR - Iran 18
ES - Italia 16
ZA - Sudafrica 16
CO - Colombia 15
UZ - Uzbekistan 15
AT - Austria 14
EC - Ecuador 13
CH - Svizzera 11
PK - Pakistan 10
CL - Cile 8
CZ - Repubblica Ceca 8
PY - Paraguay 8
AU - Australia 7
CR - Costa Rica 7
EG - Egitto 7
HN - Honduras 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
SA - Arabia Saudita 6
VE - Venezuela 6
DK - Danimarca 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
JM - Giamaica 4
KZ - Kazakistan 4
OM - Oman 4
GT - Guatemala 3
IL - Israele 3
MA - Marocco 3
NP - Nepal 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
LT - Lituania 2
LY - Libia 2
NI - Nicaragua 2
PE - Perù 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 9.064
Città #
Singapore 548
Ashburn 418
Warsaw 312
San Jose 304
Chandler 291
Beijing 112
Dublin 94
New York 89
Ho Chi Minh City 85
Fairfield 79
Jacksonville 79
San Mateo 79
Houston 75
Los Angeles 75
Ann Arbor 74
Wilmington 72
Woodbridge 65
Rome 63
Hefei 62
Lauterbourg 62
Munich 62
Jakarta 59
Dallas 54
Milan 49
Seattle 49
Boston 46
Hong Kong 46
Nanjing 45
Hanoi 44
Cattolica 41
São Paulo 40
Tokyo 39
Helsinki 38
The Dalles 38
Atlanta 35
Lawrence 33
Moscow 33
Marseille 31
Saint Petersburg 30
Dearborn 28
Nanchang 28
Santa Clara 28
Chicago 26
Council Bluffs 25
Orem 25
Cambridge 24
Brussels 21
Kent 20
Redwood City 20
Frankfurt am Main 19
Memphis 19
Princeton 18
Boardman 16
Bremen 16
London 16
Seoul 16
Tianjin 16
Brasília 15
Buffalo 15
Mountain View 15
Tashkent 15
Toronto 15
Denver 14
Haiphong 13
Turku 13
Chennai 12
Izmir 12
Montreal 12
Paris 11
Baghdad 10
Brooklyn 10
Da Nang 10
Guangzhou 10
Lancaster 10
Mexico City 10
Rio de Janeiro 10
Norwalk 9
Nuremberg 9
University Park 9
Washington 9
Bursa 8
Changsha 8
Curitiba 8
Hangzhou 8
Hebei 8
Jiaxing 8
Las Vegas 8
Ninh Bình 8
Nürnberg 8
Pune 8
San Francisco 8
Shanghai 8
Shenyang 8
Vienna 8
Belo Horizonte 7
Busto Arsizio 7
Campinas 7
Istanbul 7
Johannesburg 7
St Louis 7
Totale 4.653
Nome #
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 377
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 360
Human obesity and endothelium-dependent responsiveness 346
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 337
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 309
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 281
Oxidative stress in diabetes: implications for vascular and other complications 271
Post-surgical spontaneous paroxysmal hypothermia: a case series 259
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 239
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 194
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome 192
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review 191
Vascular Effects of Obestatin in Lean and Obese Subjects 186
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 167
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 152
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 144
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome 142
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 141
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 129
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. 128
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome 127
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 125
CD26: a multi-purpose pharmacological target 119
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. 117
Obesity and kidney disease: Beyond the hyperfiltration 116
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome 115
Variable changes of circulating angptl3 and angptl4 in different obese phenotypes: Relationship with vasodilator dysfunction 115
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 112
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. 111
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 111
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment 109
Rho Kinase Inhibition Improves Forearm Vasodilator Responsiveness During Hyperinsulinemia in the Metabolic Syndrome. 108
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue 108
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 107
Insulinemia and the risk of breast cancer and its relapse 106
Arterial ageing: from endothelial dysfunction to vascular calcification 104
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 102
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 102
Emerging pharmacological approaches for the treatment of arterial hypertension 100
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia 100
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 99
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 98
Intricacies of the endothelin system in human obesity: Role in the development of complications and potential as a therapeutic target 98
Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms 97
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunction 96
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 96
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 95
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 91
Obesity, blood vessels and metabolic syndrome 90
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 90
Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. 89
Lp-PLA 2 , a new biomarker of vascular disorders in metabolic diseases 85
Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones 83
Exercise is medicine: key to cardiovascular disease and diabetes prevention 80
Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside 79
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity 79
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 78
10th Anniversary of Biomedicines - Advances in Endothelial Dysfunction 77
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. 77
Free-amino acid metabolic profiling of visceral adipose tissue from obese subjects 76
Drug treatments to restore vascular function and diabesity 75
Anti-inflammatory and proliferative properties of luteolin-7-O-glucoside 73
Role of vitamin D in obesity 70
Obesity-related changes in the vascular actions of insulin 64
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 64
Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: A narrative review 58
Role of L-type Ca2+-channels in the vasorelaxing response to finerenone in arteries of human visceral adipose tissue 56
The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus 54
Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases 53
Is endothelin targeting finally ready for prime time? 50
Chemerin Is the Adipokine Linked with Endothelin-Dependent Vasoconstriction in Human Obesity 49
Totale 9.178
Categoria #
all - tutte 35.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022355 0 32 8 17 32 13 5 69 20 29 63 67
2022/2023859 106 110 72 116 50 116 38 72 114 27 27 11
2023/2024485 21 133 14 17 23 82 40 30 7 19 31 68
2024/20251.039 21 19 76 36 64 33 29 56 134 103 225 243
2025/20263.173 457 112 228 381 501 174 499 124 212 238 136 111
2026/20271.311 302 1.009 0 0 0 0 0 0 0 0 0 0
Totale 9.178